Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

174
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
174
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

219
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
219
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

369
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
369
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

205
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
205
Angina IV: Management01:26

Angina IV: Management

236
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
236
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

265
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
265

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

P2Y12 inhibitor monotherapy after abbreviated dual antiplatelet therapy following percutaneous coronary intervention: a meta-analysis.

European heart journal·2026
Same author

Should clopidogrel replace aspirin for long-term therapy after percutaneous coronary intervention?

Journal of cardiovascular medicine (Hagerstown, Md.)·2026
Same author

Safety and Efficacy of Colchicine across the Spectrum of Coronary Artery Disease: A Systematic Review and Meta-Analysis of 20 Randomized Trials.

Clinical pharmacology and therapeutics·2026
Same author

Dual antiplatelet therapy escalation and de-escalation.

European heart journal. Acute cardiovascular care·2026
Same author

Long-term outcomes of percutaneous coronary intervention for recurrent events in patients undergoing target-vessel vs. nontarget-vessel revascularization.

Journal of cardiovascular medicine (Hagerstown, Md.)·2025
Same author

Anti-inflammatory strategies for patients with atherosclerotic coronary disease.

Expert review of cardiovascular therapy·2025

相关实验视频

Updated: Jan 15, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

1.6K

在急性心肌梗塞后向炎症

Antonino Imbesi1, Antonio Greco1, Marco Spagnolo1

  • 1Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico-San Marco," University of Catania, Catania, Italy.

Journal of the American College of Cardiology
|October 8, 2025
PubMed
概括

急性心肌梗塞 (AMI) 后的炎症预示着心血管事件的复发. 本综述探讨了用于二次预防的抗炎疗法,突出了知识差距和不断变化的证据.

关键词:
抗炎药物是一种抗炎药物.这是一种炎症炎症炎症炎症.心肌修复是指心肌的修复.剩余的心血管风险 剩余的心血管风险有针对性的治疗.

更多相关视频

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

9.0K
Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

5.0K

相关实验视频

Last Updated: Jan 15, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

1.6K
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

9.0K
Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

5.0K

科学领域:

  • 心血管医学 心血管医学
  • 免疫学 免疫学 免疫学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 在急性心肌梗塞 (AMI) 发生后,尽管二次预防方面取得了进展,但心血管不良事件仍然存在.
  • 急性和持续性炎症后AMI是复发事件和死亡率的重要预测因素,超过低密度脂蛋白胆固醇.
  • 在AMI之后,炎症反应的调节失调可能导致慢性低度炎症和较差的临床结果.

研究的目的:

  • 为 AMI 后的炎症机制提供最新的概述.
  • 在二次心血管预防中批判性地评估抗炎疗法的临床证据.
  • 识别有关抗炎药物类效应,患者选择和最佳时间的知识差距.

主要方法:

  • 在AMI后对炎症机制的文献综述.
  • 对抗炎症药物的临床试验数据的批判性评估.
  • 综合当前关于二次心血管预防抗炎策略的证据.

主要成果:

  • 炎症在AMI后的残留心血管风险中起着至关重要的作用.
  • 几种抗炎药物正在研究中,但关于有效性和安全性的结果是相互矛盾的.
  • 关于最佳使用这些疗法存在关键知识差距.

结论:

  • 调节炎症是AMI后二次预防的一个有希望的策略.
  • 需要进一步的研究来解决药物选择,患者选择和时间的不确定性.
  • 了解炎症途径对于开发有效的抗炎治疗非常重要.